Aphena Pharma Solutions

Enters the
3PL Space

If you would like to know more

about Aphena’s 3PL launch, check back here regularly or enter your email below for updates and more information.

Aphena Icon

Aphena Pharma Solutions is proud to announce the launch of its new Third-Party Logistics (3PL) Division.

This is a natural next step for Aphena — a longtime, industry-leading provider of pharmaceutical packaging and manufacturing services — as the company continues to expand its offerings to better serve clients.

TIMELINE

Aphena plans to be ready to serve the 3PL market in late 2021 and to bring on its first clients in early 2022.

MARKET

Aphena will offer its 3PL services at reasonable rates to the prescription pharmaceutical market, with a focus on the generic subsegment as well as the over-the-counter pharmaceutical market and the nutraceutical/homeopathic markets.

CAPABILITIES

Aphena’s 3PL logistics services and capabilities will include:

  • Full distribution services (receipt, storage and order fulfillment)
  • Order-to-cash services (accounts receivable, invoicing, chargebacks and month-end close)
  • Controlled room temperature (CRT) storage
  • DEA schedule II (vault) and DEA schedule III-V storage
  • Cold chain, 2-8º Celsius storage
  • NABP DDA (VAWD) certification “in progress”
Aphena Logistics capabilities

LOCATION

Aphena’s new 3PL Division will be located on the company’s Cookeville, Tennessee, campus.

Troy Blodgett

LEADERSHIP

Aphena has chosen Troy Blodgett to serve as vice president and general manager of its Third-Party Logistics Division. Blodgett, who joined Aphena in April 2021, has more than 25 years of pharmaceutical industry experience and more than 15 years of 3PL experience, including roles at RxCrossroads, RxTPL, UPS Supply Chain Solutions and DDN.

Aphena Icon

ABOUT APHENA

Aphena Pharma Solutions is an industry-leading organization providing contract manufacturing, packaging, and now third-party logistics services, for the pharmaceutical, consumer health, biologics and medical device markets. With two separate FDA- and DEA-registered locations in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotion-based products.

Aphena meets and exceeds FDA standards for 21 CFR, Parts 111, 210, 211 and 820, and is DEA (CII-V) licensed; cGMP compliant, ISO 13485:2016 and 9001:2015 (BSI); UL Certified; and USP verified.

For more information about Aphena, visit www.aphenapharma.com or call (931) 372-2041.

CONTACT US

Please share your information below to talk to an Aphena representative about your third-party logistics needs.

1 + 8 =